FDA Inspection 982472 — Shaanxi Hanjiang Pharmaceutical Group Co., Ltd (Gaoxin site)
The FDA completed an inspection of Shaanxi Hanjiang Pharmaceutical Group Co., Ltd (Gaoxin site) on July 15, 2016 in Hanzhong. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- July 15, 2016
- Fiscal Year
- 2016
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Hanzhong (China)